Anaplastic lymphoma kinase (ALK) Modulator
-
Anaplastic lymphoma kinase (ALK) Modulator (1)
-
Rufutalkib
0 ImagesArt. -Nr.: HY-187922CAS. Nr.: 1609170-61-7Rufutalkib is an orally active ALK modulator. It possesses thermodynamic and chemical stability, and can be used in research related to anaplastic large cell lymphoma, non-Hodgkin's lymphoma, inflammatory myofibroblastic tumor, neuroblastoma, glioblastoma, and ALK-positive malignancies.
-
loading...Please select quantityAngebot einholen
August 31
-
Please select quantity
August 31
Angebot einholen
loading... -